Korean J Gastroenterol.  2018 Jul;72(1):10-14. 10.4166/kjg.2018.72.1.10.

A Single-center Experience of Esophageal Eosinophilia

• Cho KW
• Huh CW
• Jung DH
• Youn YH
• Park H

• KMID: 2416930
• DOI: http://doi.org/10.4166/kjg.2018.72.1.10

Abstract

BACKGROUND/AIMS
Esophageal eosinophilia occurs in many conditions, including eosinophilic esophagitis (EoE) and proton pump inhibitor-responsive esophageal eosinophilia (PPI-REE), which have been increasingly recognized in Western countries. There have been only a few reports in Korea. Here, we evaluated the clinical and endoscopic characteristics of patients with esophageal eosinophilia from our experience.
METHODS
Nineteen patients were diagnosed with esophageal eosinophilia based on typical symptoms, endoscopic features, esophageal eosinophilia with ≥15 eosinophils/high power field, and response to medication by PPI. Symptoms, endoscopic and pathological findings were evaluated.
RESULTS
Of the 19 patients, 2 patients were diagnosed with EoE, 7 patients were diagnosed with PPI-REE, and 10 patients were undetermined due to loss to follow-up. Among these 19 patients, dysphagia was present in 11, and heartburn, dyspepsia and reflux in 8. Sixteen patients had common endoscopic features, such as longitudinal furrows, concentric rings, strictures, and white plaques; however, 3 patients had normal findings. Nine patients underwent endoscopy at the time of follow-up. Two patients had complete resolution, and 3 had partial resolution. However, 4 patients showed no endoscopic changes. All patients showed symptom improvements.
CONCLUSIONS
The clinical and endoscopic characteristics of both groups in Korea were undistinguishable. However, after treatment, endoscopic findings were different between the two groups. Large-scale studies are warranted to confirm our findings.

Keyword

Esophagus; Eosinophilia; Proton pump inhibitors

MeSH Terms

Constriction, Pathologic
Deglutition Disorders
Dyspepsia
Endoscopy
Eosinophilia*
Eosinophilic Esophagitis
Esophagus
Follow-Up Studies
Heartburn
Humans
Korea
Proton Pump Inhibitors
Proton Pumps
Proton Pump Inhibitors
Proton Pumps

Figure

• 

  Fig. 1. Treatment outcomes. (A) Initial endoscopic finding was linear furrow, which disappeared at the follow-up endoscopy (B) with improvement of eosinophilia. (C) Initial endoscopic finding was geographic shape furrow, which was maintained or aggravated at follow-up endoscopy (D) even if, eosinophilia disappeared. (E) Initial endoscopic finding was multiple white plaques with minimal concentric rings. (F) White plaques almost disappeared, but concentric rings remained. Eosinophilia disappeared.

Reference

References

1. Molina-Infante J, Bredenoord AJ, Cheng E, et al. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2016; 65:524–531.

2. Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978; 74:1298–1301.

3. Dellon ES, Gonsalves N, Hirano I, et al. ACG Clinical Guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013; 108:679–692.

4. Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013; 108:1854–1860.

5. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011; 9:110–117.

6. Sayej WN, Patel R, Baker RD, Tron E, Baker SS. Treatment with highdose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009; 49:393–399.

7. Abe Y, Iijima K, Ohara S, et al. A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol. 2011; 46:25–30.

8. Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003; 58:516–522.

9. Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005; 115:418–419.

10. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005; 3:1198–1206.

11. Park H. An overview of eosinophilic esophagitis. Gut Liver. 2014; 8:590–597.

12. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128:3–20. e6; quiz 21–22.

13. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007; 133:1342–1363.

14. Kinoshita Y, Ishimura N, Oshima N, Ishihara S. Systematic review: eosinophilic esophagitis in Asian countries. World J Gastroenterol. 2015; 21:8433–8440.

15. Müller S, Pühl S, Vieth M, Stolte M. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy. 2007; 39:339–344.

16. Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a metaanalysis. Clin Gastroenterol Hepatol. 2012; 10:988–996.

17. Jung DH, Yun GW, Lee YJ, Jo Y, Park H. Clinicopathologic analysis of proton pump inhibitor-responsive esophageal eosinophilia in Korean patients. Gut Liver. 2016; 10:37–41.

18. Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013; 62:824–832.

19. Straumann A, Katzka DA. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterology. 2018; 154:346–359.